The HVJ liposome method

Experimental Nephrology

Volumn 6, Issue 2, 1998, Pages 144-147

  Isaka, Yoshitaka ^a   Akagi, Yoshitaka ^a   Kaneda, Yasufumi ^b   Imai, Enyu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotides; Gene therapy, glomerular diseases; HVJ liposome method, gene therapy; Transfected gene, glomeruli

Indexed keywords

LIPOSOME; VIRUS VECTOR;

CELL FUSION; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; GLOMERULUS; HUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TARGET CELL;

EID: 0031936350     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020515     Document Type: Conference Paper

References (12)

1. Kaneda Y, Iwai K, Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989;243:375-378.
2. Kato K, Nakanishi M, Kaneda Y, Uchida T, Okada Y: Expression of hepatitis B virus surface antigen in adult rat liver: Co-introduction of DNA and nuclear protein by a simplified liposome method. J Biol Chem 1991;266:3361-3364.
3. Okada Y: Sendai virus-induced cell fusion. Methods Enzymol 1993;221:18-41.
4. Bustin M, Lehn DA, Landsman D: Structural features of the HMG chromosomal protein HMG-1 and its accumulation in the cell nucleus. J Biol Chem 1990;260:10361-10368.
5. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
6. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-β1 expression by andsense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148-155.
7. Arai M, Wada A, Isaka Y, Akagi Y, Sugiura T, Miyazaki M, Moriyama T, Kaneda Y, Naruse K, Naruse M, et al: In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypjc change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Commun 1995;206:525-532.
8. Isaka Y, Fujiwara Y, Ueda K, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92:2597-2601.
9. Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T: Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992;186:129-134.
10. Miller A: Putting muscle to work for gene therapy. Nat Med 1997;3:278-279.
11. Wagner RW: Gene inhibition using antisense oligodeoxynucieotides. Nature 1994;372:333-335.
12. Morishita R, Gibbons GH, Honuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 1995;92:5855-5859.